| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Association Between Immunoparesis and Treatment Outcomes of Patients With Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis
|
Siwakoti, Ashmita
|
|
|
24 |
11 |
p. e870-e877
|
artikel
|
| 2 |
CD34 Chimerism Directed Donor Lymphocyte Infusion With or Without Azacitidine Results in Reduced Relapse and Superior Overall Survival When Full Donor Chimerism is Achieved in Allogeneic Stem Cell Transplant Recipients With Acute Myeloid Leukaemia/Myelodysplastic Syndrome
|
Tan, Joanne LC
|
|
|
24 |
11 |
p. e852-e860
|
artikel
|
| 3 |
Cereblon E3 Ligase Modulators Mezigdomide and Iberdomide in Multiple Myeloma
|
Patel, Tanvi H
|
|
|
24 |
11 |
p. 762-769
|
artikel
|
| 4 |
Consistency of Spleen and Symptom Reduction Regardless of Cytopenia in Patients With Myelofibrosis Treated With Pacritinib
|
Gagelmann, Nico
|
|
|
24 |
11 |
p. 796-803
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
24 |
11 |
p. A5-A6
|
artikel
|
| 6 |
Efficacy and Safety of Gilteritinib versus Sorafenib as Post-Transplant Maintenance in Patients With FLT3-ITD Acute Myeloid Leukemia
|
Yeh, Jason
|
|
|
24 |
11 |
p. e819-e826
|
artikel
|
| 7 |
Expression of CD6 in Aggressive NK/T-cell Neoplasms and Assessment as a Potential Therapeutic Target: A Bone Marrow Pathology Group Study
|
Zhao, Xiaoxian
|
|
|
24 |
11 |
p. e808-e818
|
artikel
|
| 8 |
Improving Access to T-Cell Therapies in Multiple Myeloma
|
Derman, Benjamin A
|
|
|
24 |
11 |
p. 759-761
|
artikel
|
| 9 |
Incidence and Clinical Presentation of Severe Neurotoxicity from Nelarabine in Patients with T-Cell Acute Lymphoblastic Leukemia
|
Braish, Julie S.
|
|
|
24 |
11 |
p. 783-788
|
artikel
|
| 10 |
Molecular Disease Monitoring in Patients With Relapsed/refractory B-Cell Lymphoma Receiving Anti-CD19 CAR T-Cell Therapy
|
Colton, Meryl
|
|
|
24 |
11 |
p. 778-782
|
artikel
|
| 11 |
Pomalidomide Use and Kidney Outcomes in Patients With Relapsed/Refractory Multiple Myeloma and Chronic Kidney Disease: A Real-World, Population-Based Cohort Study
|
Meraz-Munoz, Alejandro
|
|
|
24 |
11 |
p. e861-e869
|
artikel
|
| 12 |
Role of Autologous Stem Cell Transplantation in Systemic Light Chain Amyloidosis
|
Parmar, Harsh
|
|
|
24 |
11 |
p. 770-777
|
artikel
|
| 13 |
Safety, Efficacy, and Predictive Factors of Venetoclax-Based Regimens in Elderly Acute Myeloid Leukemia Patients: A Meta-Analysis
|
Qureshi, Zaheer
|
|
|
24 |
11 |
p. e835-e851
|
artikel
|
| 14 |
Safety of Dapsone for Pneumocystis Jiroveci Pneumonia Prophylaxis in Patients With Multiple Myeloma
|
Kim, Mingee
|
|
|
24 |
11 |
p. 804-807
|
artikel
|
| 15 |
SOHO State of the Art Updates and Next Questions: Pre-emptive Therapy at Molecular Measurable Residual Disease Failure in Acute Myeloid Leukemia
|
Tedjaseputra, Aditya
|
|
|
24 |
11 |
p. 737-751
|
artikel
|
| 16 |
SOHO State of the Art Updates and Next Questions—WHO Classification of Acute Myeloid Leukemia
|
Loghavi, Sanam
|
|
|
24 |
11 |
p. 752-758
|
artikel
|
| 17 |
Survival Among Patients With Multiple Myeloma in the United States Military Health System Compared to the Surveillance, Epidemiology, and End Results (SEER) Program
|
Dew, Alexander
|
|
|
24 |
11 |
p. 789-795
|
artikel
|
| 18 |
Survival Outcomes and Prognostic Factors in Therapy-Related Acute Myeloid Leukemia: A SEER Database Study, 2000-2020
|
Joshi, Utsav
|
|
|
24 |
11 |
p. e827-e834.e1
|
artikel
|
| 19 |
Table of Contents
|
|
|
|
24 |
11 |
p. A7-A9
|
artikel
|
| 20 |
Utility of KIT Mutations in Myeloid Neoplasms Without Documented Systemic Mastocytosis to Detect Hidden Mast Cells in Bone Marrow
|
Kim, Do Hwan
|
|
|
24 |
11 |
p. e878-e882
|
artikel
|
Tijdschrift beschrijving